#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1836	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2477	217.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1602	1602	C	239	C	222	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1836	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2477	217.9	0	HET	.	.	.	A37T	.	37	37	A	455	455	A	295	A,T	210,69	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3070	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3994	229.9	0	.	n	.	0	T695C	SNP	695	695	T	1189	1189	C	239	C,G	207,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3070	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3994	229.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1831	1831	A	263	A	244	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3070	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3994	229.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2465	2465	C	279	C,T	257,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3070	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3994	229.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3091	3091	T	257	T,C	231,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3070	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3994	229.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2539	2539	A	300	A	268	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	322	folP	852	852	100.0	folP.l15.c4.ctg.1	2197	43.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1340	1342	AGC	64;64;63	A;G;C	59;55;55	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	630	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3986	47.4	1	SNP	p	S91F	0	.	.	271	273	TCC	831	833	TCC	48;48;48	T;C;C	48;46;46	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	630	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3986	47.4	1	SNP	p	D95G	0	.	.	283	285	GAC	843	845	GAC	49;49;49	G;A;C	48;49;49	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	630	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3986	47.4	1	SNP	p	D95N	0	.	.	283	285	GAC	843	845	GAC	49;49;49	G;A;C	48;49;49	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	254	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1846	41.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	792	794	ACC	60;61;61	A;C;C	50;52;50	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	254	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1846	41.2	0	.	p	.	0	R44H	NONSYN	130	132	CGC	807	809	CAC	57;58;58	C;A;C	51;51;52	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	254	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1846	41.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	990	992	CAC	85;84;83	C;A;C	81;79;80	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	254	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1846	41.2	1	SNP	p	G45D	0	.	.	133	135	GGC	810	812	GGC	58;58;58	G;G;C	50;51;50	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	196	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1470	39.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	676	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3330	60.7	1	SNP	p	D86N	0	.	.	256	258	GAC	724	726	GAC	59;59;59	G;A;C	53;56;55	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	676	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3330	60.7	1	SNP	p	S87W	0	.	.	259	261	AGT	727	729	AGT	59;59;59	A;G;T	52;55;55	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	676	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3330	60.7	1	SNP	p	S87R	0	.	.	259	261	AGT	727	729	AGT	59;59;59	A;G;T	52;55;55	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	676	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3330	60.7	1	SNP	p	S87I	0	.	.	259	261	AGT	727	729	AGT	59;59;59	A;G;T	52;55;55	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	676	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3330	60.7	1	SNP	p	S88P	0	.	.	262	264	TCC	730	732	TCC	59;61;62	T;C;C	54;55;55	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	542	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3100	52.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1769	1771	GGC	56;56;57	G;G;C	52;51;51	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1546	1548	GCA	68;68;69	G;C;A,C	63;63;61,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1549	1551	ATC	69;69;71	A;T;C	63;62;66	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1561	1563	GTG	72;71;71	G;T;G	59;62;66	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1561	1563	GTG	72;71;71	G;T;G	59;62;66	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2065	2067	ACC	33;33;33	A,G;C;C	29,1;31;31	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2119	2121	GCG	39;39;40	G;C;G	34;32;31	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2119	2121	GCG	39;39;40	G;C;G	34;32;31	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2242	2244	GGC	45;45;45	G,T;G;C,T	39,1;39;39,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2251	2253	GGC	48;48;48	G,C,A;G;C	42,1,1;44;44	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	450	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3075	43.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2269	2271	CCG	48;48;48	C;C;G	44;43;41	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	692	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3608	57.5	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1805	1807	CTG	75;75;74	C;T;G	58;63;60	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	310	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2486	37.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	882	882	C	57	C	52	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	326	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1874	50.7	0	.	p	.	0	G50N	NONSYN	148	150	GGC	612	614	AAC	67;67;67	A;A;C	64;63;64	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	326	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1874	50.7	0	.	p	.	0	F135L	NONSYN	403	405	TTT	867	869	CTT	65;64;64	C,G;T;T	57,1;58;53	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	326	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1874	50.7	0	.	p	.	0	R143G	NONSYN	427	429	AGA	891	893	GGA	66;66;67	G;G,A;A	59;58,1;57	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	326	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1874	50.7	0	.	p	.	0	D171G	NONSYN	511	513	GAT	975	977	GGT	64;64;64	G;G,A;T	56;58,1;59	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	326	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1874	50.7	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1029	1031	AGC	69;69;69	A;G;C	64;65;65	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	326	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1874	50.7	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1095	1095	T	66	T	62	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	326	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1874	50.7	1	SNP	p	G120K	0	.	.	358	360	GGT	822	824	GGT	64;64;64	G;G;T,C	57;59;58,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	326	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1874	50.7	1	SNP	p	A121N	0	.	.	361	363	GCC	825	827	GCC	66;66;65	G,A;C,G;C,A	56,1;55,1;55,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	326	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1874	50.7	1	SNP	p	A121D	0	.	.	361	363	GCC	825	827	GCC	66;66;65	G,A;C,G;C,A	56,1;55,1;55,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1318	rpoB	4179	4179	100.0	rpoB.l6.c17.ctg.1	5448	72.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2287	2289	AAT	82;82;82	A;A;T	77;75;78	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	234	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1364	51.1	1	SNP	p	V57M	1	.	.	169	171	ATG	679	681	ATG	83;83;83	A;T;G	73;72;71	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
